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Fatigue related impairments in 
oculomotor control are prevented 
by caffeine
Charlotte J. W. Connell1, Benjamin Thompson2, Gustav Kuhn3, Michael P. Claffey4, 
Shelley Duncan1 & Nicholas Gant1
Strenuous exercise can result in an inability of the central nervous system to drive skeletal muscle 
effectively, a phenomenon known as central fatigue. The impact of central fatigue on the oculomotor 
system is currently unexplored. Fatigue that originates in the central nervous system may be related 
to perturbations in the synthesis and metabolism of several neurotransmitters. In this study we 
examine central fatigue in the oculomotor system after prolonged exercise. The involvement of 
central neurotransmission was explored by administering caffeine during exercise. Within a double-
blind, randomized, repeated measures, crossover design, 11 cyclists consumed a placebo or caffeine 
solution during 180 min of stationary cycling. Saccadic eye movements were measured using infra-red 
oculography. Exercise decreased saccade velocity by 8% (placebo trial). This effect was reversed by 
caffeine, whereby velocity was increased by 11% after exercise. A non-oculomotor perceptual task 
(global motion processing) was unaffected by exercise. The human oculomotor system is impaired by 
strenuous exercise of the locomotor system. Caffeine exerts a protective effect on oculomotor control, 
which could be related to up-regulated central neurotransmission. In addition, cortical processes 
supporting global motion perception appear to be robust to fatigue.
Exercise-induced fatigue is associated with temporary reductions in voluntary muscular force production and 
poor physical performance1. These impairments are not entirely due to biochemical processes occurring within 
skeletal muscle. A reduction in the neural drive to the working muscle is also involved - a phenomenon termed 
central fatigue.
The mechanisms responsible for central fatigue are not well understood. Perturbations in serotonergic, dopa-
minergic and noradrenergic neurotransmission observed following exercise in animal models2–4 suggest that 
central fatigue may be related to widespread alterations in neurotransmitter activity. In humans, psychotropic 
drugs that upregulate neural dopamine and noradrenaline availability improve exercise performance and extend 
time to exhaustion5–7. Pharmacological manipulation of serotonin has generated mixed findings. Studies have 
reported modified endurance performance in rodents8,9 and humans10,11, while others report no influence12–15.
Caffeine is used widely in sporting and occupational settings as a central nervous system stimulant. Caffeine 
acts as a competitive adenosine antagonist, which indirectly upregulates dopamine, and increases the synthesis 
and turnover of noradrenaline16 - a potentially valuable action for studying the role of brain catecholamines in 
the context of fatigue17. A moderate dose (3–6 mg∙kg−1BM) is associated with improvements in both cognitive18 
and physical performance19–22.
While central fatigue has been demonstrated in the skeletal motor system23–25, it is unknown whether this is a 
ubiquitous phenomenon within the brain that affects motor systems which are not directly involved in locomo-
tion and limb movement, such as the oculomotor control of eye movements. Central fatigue-like effects have been 
observed in the oculomotor system of non-human primates when measuring saccadic eye movements26. Saccades 
are rapid changes in fixation that align the foveae with salient targets in the visual field. Following hundreds 
of consecutive visually guided saccadic eye movements, there is a reduction in saccade velocity accompanied 
with parallel changes in the discharge rate of the abducens nucleus. However, microstimulation of the abducens 
nucleus pre and post fatigue produced identical saccade profiles thereby implicating processes occurring above 
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the level of the abducens nucleus as responsible for the slowing of saccade velocity26. These impairments in ocu-
lomotor function were proposed as a side effect of “mental fatigue” associated with performing a repetitive task. 
However, we hypothesize that central control of eye movements was a causal factor in reduced saccadic velocity, 
implying that the phenomenon of central fatigue may be common to the oculomotor and locomotor systems.
To test this hypothesis, we investigated whether inducing fatigue via the skeletal motor system, using an estab-
lished endurance cycling paradigm27–29, would influence the oculomotor control of saccades in humans. A key 
consideration when deriving information concerning cortical processes from eye movement kinematics is the 
extent to which the participant is attending to the task. This is important given, firstly, the role of spatial attention 
in initiating and directing volitional eye movements30, and secondly, the potential involvement of noradrenergic 
and dopaminergic neurotransmitter systems in attentional processes31. In this study, a central distractor that was 
either congruent or incongruent with the required voluntary saccade direction was integrated into the eye move-
ment task to provide a measure of visual attention32.
In addition, fatigue may influence visual perception, which could subsequently affect performance of a sacca-
dic eye movement task. Global motion processing is a well characterised aspect of visual perception that involves 
integration of information from directionally sensitive neurons in the primary visual cortex within extrastriate 
areas of the dorsal visual processing stream33,34. Global motion coherence thresholds can be derived using ran-
dom dot kinematograms (RDK), and provide an indication of dorsal stream function35. As dorsal stream function 
has been linked to the control of eye movements34, we obtained psychophysical measures of global motion per-
ception to account for any influence of central fatigue on extrastriate visual function.
The present study used a three-hour cycling exercise protocol to provide a physiological challenge capable of 
inducing central fatigue. Prolonged strenuous cycling has been shown to decrease cortical activation of the knee 
extensors for up to 45 minutes following exercise cessation36 and alter cerebral energetics27–29. We investigated the 
effects of fatigue on the oculomotor control of saccadic eye movements, visual attention and global motion per-
ception. Caffeine was administered to explore the possible role of noradrenergic and dopaminergic transmission 
on fatigue. We hypothesized that exercise-induced fatigue would compromise the oculomotor control of saccades 
without concurrent alterations to visual attention and extrastriate visual function. In addition, we predicted that 
decrements in oculomotor control following fatiguing exercise are related to widespread changes in dopamine 
and noradrenaline activity, and thus, will be reversed with caffeine.
Experimental procedures
Participants. Twelve well-trained cyclists (6 males, maximal aerobic capacity 57 ± 1 ml∙kg∙min−1) with a 
mean age of 23 (20–31) years and body mass of 70 ± 4 kg, volunteered to participate. Participants gave written 
informed consent and visited the laboratory on three occasions to participate in a protocol conducted in accord-
ance with the Declaration of Helsinki and approved by the University of Auckland ethics committee.
Experimental design. A moderate dose of caffeine (5 mg·kg−1 body mass) was administered within a 
double-blind, placebo-controlled, repeated measures, randomised cross-over design. Participants completed two 
experimental trials involving 180 min of continuous cycling with a self-selected cadence at a work rate equivalent 
to 60% of maximal aerobic capacity with a minimum of 7 days between cross-over phases. In both experimental 
trials, baseline measures for each participant were obtained prior to exercise (pre exercise), and immediately 
following the completion of exercise (post exercise). Participants were asked to abstain from caffeine-containing 
items, such as coffee and tea, for the 24 hours before each experimental session. During exercise, a carbohydrate 
solution (0.7 g carbohydrate·kg−1·h−1) was ingested at 15 min intervals during the cycling protocol with a caffeine 
powder added to the beverage ingested at 90 min for the caffeine treatment. Caffeine reaches a maximum plasma 
concentration approximately 1 hour after ingestion and has a half-life of 4 to 6 hours. The timing of the dose was 
chosen in an attempt to coincide peak action of caffeine with the post-exercise measures. The mean rates of fluid 
and carbohydrate ingestion were 611 ± 34 ml∙kg−1∙hr−1 and 49 ± 3 g∙hr−1 respectively.
Preliminary Tests. At least 1 week prior to the experimental protocol participants performed a maximal 
cardiopulmonary exercise test on an electromagnetically braked cycle ergometer (Velotron Dynafit Pro, Seattle, 
WA, USA) with respiratory gas analysis equipment (MetalyzerII and Metasoft 3.9, Cortex, Germany) to measure 
peak oxygen uptake. VO2max was estimated and used to prescribe a power output that required 60% VO2max for 
the experimental trials.
Experimental protocol. Participants arrived at the laboratory at 8 am following a 12 h overnight fast. Prior 
to exercise, pre-exercise body mass was collected and participants performed visual performance tasks. Maximal 
isometric voluntary force production for handgrip and knee extension of the dominant arm and leg were meas-
ured using a handgrip dynamometer and a modified leg extension machine (Body Solid, IL, USA) respectively. The 
knee was held at 45° extension to perform the contraction while the handgrip dynamometer was held with a ‘power 
grasp’. Maximal voluntary contractions were held for 3 seconds and repeated 5 times with 20 seconds rest between 
each contraction. Participants then completed the exercise protocol. Heart rate was monitored continuously 
throughout the exercise, and visual analogue scales were used to rate perceived exertion, valence and felt arousal 
at 15 min intervals. After exercise, participants completed the visual performance tasks followed by force produc-
tion tasks and body mass measurement. The pre and post exercise visual performance and isometric strength tasks 
were completed within 30 min. Time spent between exercise and the visual performance tasks was kept below 
2 min by performing the cycling exercise intervention and the visual tasks in the same room. A saccade task ran 
for a fixed duration of 6 min 8 sec while a motion coherence task required an average duration of 10 min ± 15 sec 
to complete. Maximal isometric handgrip and leg extension force required approximately 10 minutes 
to complete.
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Visual performance measures. Saccadic eye movements in response to computer generated visual stim-
uli were measured with a head-fixed eye tracking system at a sampling rate of 60 Hz (ViewPoint Eye Tracker, 
Arrington Research Systems, Scottsdale, USA).
The display screen was positioned at a viewing distance of 750 mm. Following a 16-point calibration proce-
dure, participants fixated their gaze on a central fixation point embedded within a schematic face (8.57° in diam-
eter) with two eyes (2.27° in diameter). The face was flanked by two solid black target circles (0.91° in diameter, 
10° from centralised fixation point) (Fig. 1). Participants were instructed to observe the change in colour of the 
central fixation point (e.g. red = saccade to the right and green = saccade to the left) and perform the correspond-
ing saccade to fixate on the peripheral target circle. The mapping of colour to saccade direction was randomized 
across participants. Simultaneously with the saccade instruction, the pupils of the schematic face moved to the 
left or the right. On congruent trials, the instructed saccade direction was in the same direction as the distractor 
eyes, while on incongruent trials, they were in opposite directions (Fig. 1).
Each test comprised 25 trials of each congruency condition (congruent/incongruent) and stimulus (red/
green) combination. These were randomised throughout the test. In total, 100 saccades took 6 min 8 sec to com-
plete. Stimulus presentation, data collection and data analysis were performed using custom software written in 
Matlab (MathWorks R2010b, Massachusetts, USA). Initiation of a saccade was defined as an initial deviation of 
> 1° from fixation and a velocity of ≥ 30°∙s−1. The end of the saccade was detected by a drop in the saccade velocity 
below 30°∙s−1 37,38.
Global motion perception was assessed with random-dot kinematograms, which consisted of two groups of 
moving dots; coherent (signal) dots all moved in the same direction whereas noise dots moved randomly. The 
two-alternative-forced-choice test required participants to report which direction coherently moving dots were 
Figure 1. Schematic of the social attention saccadic eye movement paradigm. Participants fixated on a 
central point that was embedded within a schematic face. On each trial participants were required to saccade 
to a target 10° to the left or right of fixation depending on whether the fixation point turned red or green. 
Simultaneous with the colour change of the fixation point, pupils appeared in the eyes of the schematic face that 
generated a leftward or rightward direction of gaze. It has been demonstrated that this gaze cue rapidly captures 
attention and facilitates or disrupts task performance depending on whether the gaze direction is congruent or 
incongruent with the required voluntary saccade direction.
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travelling (left or right). The proportion of coherently moving dots was titrated with a 3-up 1-down staircase pro-
cedure to determine the lowest signal-to-noise threshold (global motion coherence threshold) that was necessary 
for participants to report leftward or rightward motion. The staircase had a proportional step size of 50% before 
the first reversal and 12% thereafter. There were eight reversals, and the average of the last six was taken as the 
threshold. Stimuli were presented on a cathode ray tube (CRT) display screen with a viewing distance of 750 mm. 
The radius of the stimulus aperture was 5°. However, dots did not travel within the central 1° to prevent interac-
tion with the central fixation point. Dot diameter was 0.2°, speed was 5°∙s and central fixation point diameter was 
0.4°. Stimulus duration was 500 ms and dots were presented at 100% contrast on a mean luminance background. 
Dots had a limited lifetime whereby there was a 25% chance of the dot being deleted and redrawn in a random 
location on each frame; this was to prevent participants tracking an individual dot and, therefore, encouraged 
global integration of the stimuli.
Data treatment and analysis. Two-way repeated measures analysis of variance with factors 
INTERVENTION (Caffeine/Placebo) and TIMEPOINT (pre-exercise/post-exercise) were used to determine 
the effect of intervention (placebo or caffeine) on maximal voluntary force production, fluid balance, subjective 
experiences, heart rate and global motion perception. CONGRUENCY (congruent/incongruent) was added as a 
factor to statistical analyses for saccade kinematic measures – average velocity, latency, accuracy (absolute devi-
ation from target in degrees), task performance and task efficiency (saccade latency divided by the proportion of 
correct saccades). Where necessary, interaction effects were explored using within-subject paired comparisons, 
or using one sample comparisons when comparing measures relative to baseline. The multiple comparison type I 
error rate was controlled using a modified Bonferroni procedure39. Results are reported as mean ± standard devi-
ation (SD) for n = 11 in visual performance, subjective measures, and physiological measures (heart rate, body 
mass, grip strength) unless otherwise stated. One participant’s saccade data was excluded from statistical analyses 
due to a recording error. One participant was unable to reliably perform the motion coherence tests. A third was 
unable to completely perform strength and mood measurements. Results for knee extension are reported for 
n = 10. The significance level was set at p < 0.05. To investigate the magnitude of changes across time point, effect 
sizes were reported for certain measures. Effect size was calculated as the difference between the post exercise and 
the pre exercise outcomes divided by pre exercise SD as follows40:
= − .Effect size mean mean /SDpost exercise pre exercise pre exercise
Results
Visual Performance Measures. There was an effect of exercise-induced fatigue on saccade velocity 
that was modulated by intervention and congruency (3-way interaction INTERVENTION × TIMEPOINT × 
CONGRUENCY, F1,10 = 8.076, p < 0.05). Changes in saccade velocity from baseline were larger in magnitude 
and less variable for congruent saccades compared to incongruent saccades (Fig. 2, Panel a). Post-hoc analysis 
revealed that exercise-induced fatigue significantly reduced the velocity of congruent saccades compared to base-
line by 8 ± 11% (t10 = − 2.349, p < 0.05) in the placebo trial. Figure 2 (Panel b) depicts average saccade velocity 
for congruent saccades across time points for placebo (left panel) and caffeine (right panel) interventions for each 
participant. In the majority of the participants, saccade velocity was influenced by exercise-induced fatigue, with 
nine of eleven participants exhibiting a lower average saccade velocity post exercise compared to pre exercise 
in the placebo trial. To explore the magnitude of this change while accounting for within-subject variability, 
an effect size comparing pre exercise saccade velocity to post exercise saccade velocity was calculated for each 
participant. The average effect size of the nine participants that displayed a drop in average saccade velocity in 
the placebo trial was 0.4 ± 0.3. The remaining two participants displayed an increase in average saccade velocity 
post exercise with an average effect size of 0.3 ± 0.2. Three participants experienced a moderate to large drop in 
average saccade velocity post exercise (effect size > 0.5). These participants are highlighted on Fig. 2 (left panel b) 
with a dashed line, while participants showing an effect size < 0.5 are plotted with a solid line. Conversely, a 
moderate dose of caffeine during exercise maintained congruent saccade velocity at baseline levels, although a 
trend toward increased saccade velocity compared to baseline was present (11 ± 22%, t10 = 1.659, p = 0.064) (see 
Fig. 2, Panel a). Saccade velocity was maintained or increased in the caffeine trial for the majority of participants 
(nine out of eleven) (Fig. 2, right panel b). The average effect size of these nine participants was 0.5 ± 0.4. The 
remaining two participants exhibited a decrease in post exercise saccade velocity with an average effect size of 
0.6 ± 0.17. In six participants there was a moderate change in average saccade velocity (effect size > 0.5) post 
exercise with caffeine. Five of these participants exhibited a moderate to large (0.5–1.2 effect size) increase in 
congruent saccade velocity following exercise, while two participants displayed a moderate decrease in saccade 
velocity after exercise. These data are highlighted on Fig. 2 (right panel b) with a dashed line, while participants 
showing an effect size < 0.5 are plotted with a solid line.
A robust main effect of congruency was observed for saccade latency (F1,10 = 27.083, p < 0.01) and task error 
(F1,10 = 21.777, p < 0.01), whereby shorter latencies and fewer incorrect saccades (i.e. saccades in the opposite 
direction to the fixation point colour cue) were made in the congruent condition compared with the incongruent 
condition. No changes were observed pre to post exercise or between interventions for saccade latency, accuracy 
or task error. These data are summarised in Table 1.
Task efficiency was calculated by dividing saccade latency by the proportion of saccades in the correct direc-
tion. This metric provides an indication of absolute task performance, with lower values representing more effi-
cient performance41. Task efficiency was similar across all levels of intervention and time point. As expected, a 
main effect of congruency was present (F1,10 = 40.240, p < 0.01). Task efficiency was enhanced in response to 
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congruent stimuli compared to incongruent stimuli (see Fig. 2, Panel c). The magnitude of this congruency effect 
was comparable across interventions and time points, with no significant effect of caffeine on task efficiency.
Figure 2. Saccade velocity and task efficiency for placebo (left panel) and caffeine (right panel) treatments. 
(Panel a) - Percentage change in post exercise average saccade velocity compared to pre-exercise. Significance 
labelling above bars show one sample comparisons relative to baseline (0 min). (Panel b) - Congruent average 
saccade velocity pre exercise and post exercise in placebo and caffeine treatments. Each point represents mean 
saccade velocity ± 95% confidence interval for each participant. Dashed lines represent participants exhibiting 
a pre to post exercise change in congruent saccade velocity with an associated effect size > 0.5. (Panel c) - Task 
efficiency (saccade latency divided by proportion of correct saccades). Significance labelling between congruent 
and incongruent saccade lines indicate a main effect of congruency. Left panel shows data collected in placebo, 
right panel shows data collected in caffeine trial. Data represent mean ± SE. *≤ 0.05.
Placebo Caffeine
Congruent Incongruent Congruent Incongruent
Average Velocity (°∙s−1)
Pre 148 ± 24* 147 ± 21 138 ± 23 140 ± 27
Post 136 ± 19* 140 ± 22 150 ± 25 148 ± 23
Accuracy (˚ off target)
Pre 3.7 ± 0.8 3.6 ± 0.7 4.0 ± 1.1 4.0 ± 1.2
Post 4.0 ± 1.7 3.6 ± 0.7 3.5 ± 1.0 3.6 ± 1.0
Latency (ms)
Pre 417 ± 45 433 ± 54 415 ± 37 441 ± 47
Post 436 ± 63 467 ± 76 420 ± 33 438 ± 38
Error (%)
Pre 1.5 ± 2 13.9 ± 12 2.0 ± 2 12.3 ± 9
Post 1.2 ± 1 10.7 ± 8 1.5 ± 2 11.9 ± 8
Task Efficiency 
Pre 424 ± 47 510 ± 83 424 ± 42 504 ± 43
Post 441 ± 65 524 ± 84 427 ± 36 500 ± 48
Table 1.  Visual performance measures obtained during the saccade task paradigm. Data represent 
mean ± SD. A main effect of congruency was observed for latency, error and task efficiency. This congruency 
effect did not differ between interventions (Placebo and Caffeine), or time point (pre to post exercise). 
Significance labelling above text show post-hoc paired sample comparisons pre to post exercise. *≤ 0.05.
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There were no effects of intervention on global motion perception. A main effect of time was detected for 
motion perception threshold (Fig. 3, Panel a). Post-hoc analyses revealed a significant pre to post exercise 
improvement for the placebo trial, with thresholds dropping from 21 ± 10% pre-exercise to 18 ± 6% post exercise 
(t10 = 2.669, p < 0.05). There was a trend for motion coherence to improve pre to post in the caffeine trial (18 ± 6% 
to 16 ± 7% respectively), however this did not reach statistical significance (t10 = 2.118, p = 0.060). An additional 
repeated measures ANOVA performed on these data to explore potential task learning revealed main effects of 
trial order (F1,10 = 18.680, p < 0.01) and time point (F1,10 = 16.135, p < 0.01), suggesting that motion coherence 
threshold was improved in experimental trial two compared to trial one, and pre exercise to post exercise, irre-
spective of the intervention received.
Physiological and physical performance measures. Heart rate response and fluid loss were equivalent 
between interventions. For placebo and caffeine trials average heart rate (beats per minute) was 152 ± 17 and 
154 ± 14 (F1,11 = 1.192, p = 0.298), respectively. Mean change in body mass was − 0.4% ± 0.5% and − 0.7% ± 0.6% 
of pre exercise body mass, for placebo and caffeine trials respectively. Knee-extension force decreased by a sim-
ilar magnitude for placebo and caffeine (− 11% ± 12% and − 10% ± 12% respectively) (F1,9 = 12.680, p < 0.05). 
Grip strength did not decrease following exercise (− 3% ± 7% and − 2% ± 4% pre and post exercise respectively) 
(F1,9 = 3.000, p = 0.117) or differ between interventions (F1,9 = 0.464, p = 0.513).
Subjective Experiences. Figure 3, Panel b shows average ratings of perceived exertion and felt arousal for 
placebo and caffeine interventions. A main effect of time (F10,100 = 6.915, p < 0.05) and interaction between trial 
and time (F10,100 = 166.855, p < 0.05) was detected for ratings of perceived exertion. Ratings in perceived exertion 
remained similar for both treatments until 120 minutes, where perceived exertion was reduced in the caffeine 
trial. Post-hoc analyses revealed significant differences in perceived exertion at the 120 min (t10 = 3.882, p < 0.01) 
and 165 (t10 = 3.820, p < 0.01) min time points.
Similarly, a main effect of time (F10,100 = 2.601, p < 0.05) and interaction between trial and time 
(F10,100 = 6.855, p < 0.05) was evident for felt arousal. Following the ingestion of caffeine at 90 min, there was 
a reversal in the trend of declining arousal with the progression of the exercise protocol. However, in the pla-
cebo trial this downward trend in arousal continued. Significant differences in arousal at time points 135 min 
(t10 = 3.193, p < 0.05) and 165 min (t10 = 3.224, p < 0.05) were revealed in post-hoc statistical tests.
Figure 3. Motion perception, effort sense and arousal for placebo (white fill) and caffeine (black fill) 
treatments. (Panel a) - motion coherence threshold (minimum motional signal required to discriminate 
coherent motion from random noise). Significance labelling with comparator bars show paired sample 
comparisons of baseline motion coherence (0 min) to post exercise coherence (180 min). (Panel b) - perceived 
exertion and felt arousal. Data represent mean ± SE. Significance labelling above individual points show paired 
sample comparisons of caffeine to placebo interventions. *≤ 0.05.
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Discussion
This is the first study to show impaired control of eye movements following fatiguing exercise. Prolonged use of 
the skeletal motor system influences the function of the oculomotor system, implicating a possible role of central 
fatigue. Caffeine is capable of countering this effect, suggesting that central fatigue may be related to a disruption 
in the balance of one or more excitatory and inhibitory neurotransmitters.
Saccadic eye movements were significantly slower after three hours of prolonged cycling in the placebo con-
dition. This effect was seen as decreased average velocity for congruent saccades. Concurrent changes in saccade 
accuracy were not observed. Thus, decrements in average saccade velocity were not simply attributable to alter-
ations in the distance travelled during the saccade. This is in line with observations in non-human primates, 
whereby saccade peak velocities and duration, but not amplitude, progressively changed during a fatiguing eye 
movement paradigm26. We observed an 8% reduction in average saccade velocity for 10 degree saccades after 
exercise in the placebo condition. Eight of eleven participants displayed a post exercise drop in saccade velocity 
with an associated effect size of > 0.2. Whether a velocity reduction of this magnitude has an impact on visual 
function is currently unknown. However, it is conceivable that exercise induced velocity reductions may have a 
greater impact on larger amplitude saccadic eye movements and that this may impact on visual performance.
Saccadic velocity was preserved post exercise in the caffeine trial, with nine of eleven participants exhibiting 
either no change or a small to moderate increase in saccade velocity post exercise. Caffeine exerts a stimulant 
effect on the central nervous system through competitive antagonism at the level of adenosine receptors, result-
ing primarily in increased rates of noradrenaline synthesis and turnover, and indirect enhancement of endoge-
nous dopamine release16. Noradrenaline has been linked to the control of saccadic eye movements. Following 
the administration of clonidine, an α 2-adrenoreceptor agonist that inhibits noradrenaline release, peak saccade 
velocity, acceleration and deceleration slowed substantially42. Conversely, when clonidine and caffeine were 
administered together, these decrements in saccade velocity were reversed, however, when caffeine was admin-
istered alone it did not increase saccade velocity above control values43. Similarly, the administration of an α 
2-adrenoreceptor antagonist, which enhances noradrenaline release, did not increase saccade velocity, accelera-
tion or deceleration above baseline measures42. This suggests firstly, that the introduction of a significant home-
ostatic perturbation is required in order to disrupt aspects of saccade control, and secondly that the “default 
setting” for saccade control is optimal under normal circumstances. Given this, it is plausible that 3 hours of 
prolonged fatiguing exercise provides sufficient inhibitory tone to disrupt average saccadic velocity, possibly by 
affecting brain areas involved in saccadic eye movement control such as the superior colliculus, frontal eye fields, 
supplementary eye fields, and the paramedian pontine reticular formation. We propose that caffeine is able to 
maintain saccadic control at pre exercise levels by offsetting the alterations introduced by exercise-induced central 
fatigue through the up-regulation of central neurotransmission. However, caffeine also has several peripheral 
actions, including increased mobilization of intracellular calcium, and inhibition of phosphodiesterases44, which 
could alter the contractile properties of muscle. A 50 mg dose of caffeine increases muscle twitch force at low 
firing frequencies in skeletal muscle45, which could influence saccade velocity if the extra-ocular muscles were 
similarly affected. Further investigation is required to ascertain the influence of a moderate dose of caffeine on 
measures of oculomotor control at rest.
Visual attention appears robust to exercise-induced central fatigue, as a clear congruency effect, similar in 
magnitude across all interventions and time points, was observed for saccade latency, task performance and task 
efficiency. This congruency effect stems from the biological salience of the eye-gaze distractor within the saccade 
task, as humans tend to allocate greater attention to the eyes compared to other parts of the body46. The eye-gaze 
distractor in our social attention saccade paradigm promotes a reflexive orienting of attention in the direction of 
the eye-gaze32,47. Thus, in the congruent condition, the eye-gaze distractor facilitated the attention shift required 
to perform an appropriate oculomotor response, leading to shorter saccade latency, improved task performance, 
and greater task efficiency. For the incongruent condition, the eye-gaze distractor was effective in disrupting task 
performance, increasing the processing time required for attention shifting, thus decreasing task efficiency and 
increasing saccade latency. Administration of caffeine did not improve this measure of visual attention, although 
it did promote higher subjective ratings of felt arousal and lower ratings of perceived exertion. The pattern 
observed in perceived exertion and arousal during the caffeine trial confirms adequate dosing, as our measures 
are consistent with previous reports documenting responses to caffeine during prolonged cycling exercise48.
Similar to visual attention, visual processing in extrastriate areas of the dorsal stream, which support global 
motion processing, are seemingly robust to exercise-induced fatigue regardless of caffeine status. Motion coher-
ence thresholds significantly decreased pre to post exercise in the placebo trial, while there was a non-significant 
trend in the same direction in the caffeine trial. Our data suggest that global motion detection and dorsal stream 
function are resistant to the perturbations associated with fatigue that compromise motor control. This may be 
valuable for the preservation of wider visual function given the fundamental role that motion detection and 
dorsal stream function play in perception, cognition and action35. The improvements seen in global motion 
coherence threshold post exercise are likely to be a consequence of within-trial task learning, which is a known 
property of global motion testing49. This effect was minimized as much a possible by providing practise sessions 
prior to the first baseline measurement.
In this study, equivalent physiological stress was imposed during both nutritional interventions. The same 
amount of work was performed for each trial, fluid balance was maintained pre to post exercise, and heart rate 
did not differ between trials. By adopting a well-established carbohydrate supplementation strategy27,50, we pro-
moted adequate substrate availability and the maintenance of euglycaemia for both interventions. The working 
skeletal muscles were fatigued to the same extent in both trials, as demonstrated by a consistent decrease in 
knee-extensor force. Fatigue was not detectable in maximum voluntary contractions of upper limb skeletal mus-
cle, with handgrip force similar for all pre and post conditions. In three-hour cycling protocols where hypoglycae-
mia is induced, a significant attenuation in voluntary activation of the knee extensors occurs50, cerebral ammonia 
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uptake is increased28, and other markers of perturbations in cerebral metabolism are detected27. Consequently, it 
appears that substrate depletion may exacerbate the effects of central fatigue - a possibility yet to be explored in 
the oculomotor system.
This study provides evidence for an effect of central fatigue on the oculomotor system, whereby fatigue 
induced by prolonged cycling exercise influences oculomotor control. The oculomotor system is functionally 
independent of locomotion and was not challenged in this study, so our observation cannot be explained by direct 
functional stress within the brain circuitry controlling the extra-ocular muscles. Caffeine appears to preserve 
average saccadic velocity at pre exercise levels, possibly via a stimulant effect on the central nervous system.
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